Workflow
沃森生物:公司将继续深入拓展海外销售合作渠道

Core Viewpoint - Watson Bio's subsidiary, Yuxi Watson Biotechnology Co., Ltd., has successfully completed its first export delivery of the 23-valent pneumococcal polysaccharide vaccine to El Salvador, providing significant support for pneumonia prevention among high-risk populations in the region [1] Group 1 - The vaccine supply to El Salvador marks a strategic expansion into international markets for the company [1] - The company aims to continue developing overseas sales channels to maintain high-quality growth in its international business [1]